About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
State of the Art and Next Questions: Management of MCL
By
SOHO Highlights: State of the Art and Next Questions
FEATURING
Andre Goy
By
SOHO Highlights: State of the Art and Next Questions
FEATURING
Andre Goy
0 views
March 27, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Featured Video
16:26
Incyte
Effects of a Treatment Option on Hematocrit Control and Spleen Volum…
Feat.
C. Harrison
Recommended
AUTOPLAY
ON
Related
Newest
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
Feat.
B. D. Cheson
25:47
Massachusetts General Hospital Cancer Center
Practice-Changing Updates in Indolent B-Cell Lymphomas
Feat.
J. Soumerai
31:12
UChicago Medicine
Practice-Changing Abstracts in NHL and HL From ASH 2023
Feat.
S. Smith
18:24
Memorial Sloan Kettering Cancer Center
Key Lymphoma Updates From ASH
Feat.
P. Torka
37:44
University of Colorado Division of Hematology
Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas
Feat.
M. Kamdar
10:27
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…
Feat.
J. DiPersio
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Overview of Hematopoietic Cell Transplantation
Feat.
R. Salit
25:23
Indy Hematology Review
When Not to Watch and Wait: Emerging Strategies in the Treatment of …
Feat.
M. Williams
17:30
SOHO Brazil 2024
Making Sense of 1L Treatment Options in MCL
Feat.
T. Phillips
26:58
Total Health
Update on Cellular Therapy in Lymphoma
Feat.
B. Randolph
04:34
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Highlights and Key Takeaways in MCL"
Feat.
P. Jain
18:50
MyCancerHaven
CLL and MCL: Experts Discuss the Use of Pirtobrutinib
Feat.
R. Vij,
G. Shouse
22:38
Indy Hematology Review
Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…
Feat.
T. Phillips
16:05
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is High Risk MCL and How Should We Treat It
Feat.
A. Kumar
06:43
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of MCL - Highlights & Key Takea…
Feat.
V. Yazbeck
15:18
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Practical Updates on Advances in CLL and MCL
Feat.
E. Chong
07:22
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Hypertension in Pts With CLL and Other Heme…
Feat.
A. Ferrajoli
14:34
Northwestern Medicine Oncology and Hematology
EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial
Feat.
L. Gordon
05:24
Chan Cheah
Efficacy of Pirtobrutinib in Covalent BTKi Pre-Treated R/R MCL: Addi…
